Protagenic Therapeutics Share Price (NASDAQ: PTIX)
$3.6
▲
0.05
(1.41%)
Last updated on
Check the interactive Protagenic Therapeutics Stock chart to analyse performance
Protagenic Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$3.60Today's High:$3.67
0.0%
Downside
Day's Volatility :1.91%
Upside
1.91%
- 52 Weeks Low:$2.2552 Weeks High:$15.54
37.5%
Downside
52 Weeks Volatility :85.52%
Upside
76.83%
Protagenic Therapeutics Stock Returns
Protagenic Therapeutics Inc Key Stats
Check Protagenic Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Protagenic Therapeutics Stock including INR - Dollar returns
The Protagenic Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Protagenic Therapeutics investment value today
Current value as on today
₹48,868
Returns
Returns from Protagenic Therapeutics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Protagenic Therapeutics Stock
Global Institutional Holdings in Protagenic Therapeutics Inc
Name
Holdings %
Alpine Partners VI, LLC
2.78%
Geode Capital Management, LLC
0.94%
Virtu Financial LLC
0.67%
State Street Corp
0.17%
Tower Research Capital LLC
0.15%
Citigroup Inc
0.07%
Analyst Recommendation on Protagenic Therapeutics Stock
Buy
85%Buy
14%Hold
0%Sell
Based on 7 Wall street analysts offering stock ratings for Protagenic Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Protagenic Therapeutics Share Price Target
What analysts predicted
Upside of 11.11%
Target:
$4.00
Current:
$3.60
Protagenic Therapeutics share price target is $4.00, a slight Upside of 11.11% compared to current price of $3.60 as per analysts' prediction.
Protagenic Therapeutics Stock Insights
Price Movement
In the last 7 days, PTIX stock has moved down by -14.6%PTIX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 127.2%PTIX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 207.3%
Protagenic Therapeutics Technicals Summary
Sell
Neutral
Buy
Protagenic Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Protagenic Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 33.09% | -6.42% | -56.19% | -91.26% | -97.11% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 2.49% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | 0.0 | 0.0 | -5.13 | -1.9 | NA | -0.16 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $3.4M | -97.11% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Protagenic Therapeutics Inc
Key Management of Protagenic Therapeutics Inc
Important FAQs about investing in PTIX Stock from India :
What is Protagenic Therapeutics share price today?
Protagenic Therapeutics share price today is $3.60 as on at the close of the market. Protagenic Therapeutics share today touched a day high of $3.67 and a low of $3.60.
What is the 52 week high and 52 week low for Protagenic Therapeutics share?
Protagenic Therapeutics share touched a 52 week high of $15.54 and a 52 week low of $2.25. Protagenic Therapeutics stock price today i.e. is closed at $3.60, lower by 76.83% versus the 52 week high.
How to invest in Protagenic Therapeutics Stock (PTIX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Protagenic Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protagenic Therapeutics Shares that will get you 0.4167 shares as per Protagenic Therapeutics share price of $3.60 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Protagenic Therapeutics Stock (PTIX) from India?
Indian investors can start investing in Protagenic Therapeutics (PTIX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Protagenic Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Protagenic Therapeutics share’s latest price of $3.60 as on August 30, 2025 at 1:29 am IST, you will get 2.7778 shares of Protagenic Therapeutics. Learn more about
fractional shares .
What are the returns that Protagenic Therapeutics has given to Indian investors in the last 5 years?
Protagenic Therapeutics stock has given -97.11% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%